Lineage Cell Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Enrollment Continues in Phase 2a Clinical Study of RG6501 in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration Under Management of Genentech, a Member of the Roche...